ICR acquires Consilium to create global powerhouse in healthcare strategic communications

ICR, a global strategic communications and advisory firm, has acquired Consilium Strategic Communications, a London-based market leader in healthcare strategic communications and investor relations. This move combines nearly 200 clients and over 100 team members across three continents under the newly-formed “ICR Consilium” brand. The acquisition strengthens ICR’s healthcare practice and marks its first official presence in Europe.

ICR and Consilium: A Union Offering Comprehensive Global Support in Healthcare

Current clients of Consilium will immediately benefit from a broader range of ICR’s services, including investor relations, IPO advisory, and ESG guidance, among others. The acquisition sets the stage for integrated support across all service platforms, offering existing and new clients of ICR Consilium access to comprehensive healthcare advisory services globally.

Tom Ryan, Founder & CEO of ICR, said: “Consilium has long been recognized as the preeminent healthcare communications and advisory firm across Europe and our years of collaboration have allowed us to learn first-hand what makes them so unique. MJ, Amber and their team have built an incredible business, with a hard-earned reputation for deep sector expertise, highly strategic counsel and outstanding client service. Their business and culture could not align more perfectly with ICR’s and we are thrilled to advance our partnership as a single, unified team.”

Leadership Team and Future Growth Plans

Mary-Jane Elliott, Founder and Managing Partner of Consilium, will continue to lead the firm from its London headquarters. Both she and Senior Partner and Co-founder Amber Fennell will join ICR’s healthcare leadership team. Mary-Jane Elliott added, “I am excited by our next phase of growth as part of ICR, who are backed by two leading global private equity firms – CDPQ and Investcorp, and what opportunities this offers, particularly in the US, to our clients and colleagues. Now is the right time to deepen that relationship, which coincides with hopefully the continued re-opening of the capital markets, and we look forward to what we can accomplish together.”

ICR Expands Capabilities and Service Offerings in Europe

This transaction greatly enhances ICR’s capabilities in Europe by expanding its practice size in both revenue and headcount, and by broadening its range of service offerings. It enables the combined team to support healthcare businesses with a full range of strategic communications and investor relations services.

Depth of Expertise Across Healthcare Subsectors

ICR Consilium brings unparalleled depth of expertise in healthcare advisory services across various subsectors including biopharma, medical technology, and diagnostics. The firm’s extensive range of strategic communication and investor relations services fortifies its capabilities to support healthcare companies through all stages of growth, making it one of the largest global specialist healthcare communications practices.

This acquisition follows nearly a decade of joint venture collaboration between ICR and Consilium, solidifying a complementary international fit in healthcare PR and investor relations advisory work. It offers exciting new growth opportunities and gives both firms an unrivaled network across the US, UK, continental Europe, and Asia.